Association between bone mineral density and type 2 diabetes mellitus: A meta-Analysis of observational studies

European Journal of Epidemiology

Volumn 27, Issue 5, 2012, Pages 319-332

  Ma, Lili ^a   Oei, Ling ^b   Jiang, Lindi ^a   Estrada, Karol ^b   Chen, Huiyong ^a   Wang, Zhen ^a   Yu, Qiang ^a   Zillikens, Maria Carola ^b   Gao, Xin ^a   Rivadeneira, Fernando ^b  

^a FUDAN UNIVERSITY   (China)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Bone mineral density; Meta Analysis; Type 2 diabetes

Indexed keywords

HEMOGLOBIN A1C;

AGE; BODY MASS; BONE DENSITY; CASE CONTROL STUDY; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMUR NECK; FOREARM; HIP; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; REVIEW; SEX DIFFERENCE; SPINE; SYSTEMATIC REVIEW;

AGE FACTORS; BIOLOGICAL MARKERS; BODY MASS INDEX; BONE DENSITY; DIABETES MELLITUS, TYPE 2; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; REGRESSION ANALYSIS; SEX FACTORS;

EID: 84863726590     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-012-9674-x     Document Type: Review

References (90)

1. Albright F, Reifenstein EC. The parathyroid glands and metabolic bone disease: Selected studies. Baltimore: Williams and Wilkins; 1948.
2. Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes-A metaanalysis. Osteoporos Int. 2007;18(4):427-44. doi:10.1007/ s00198-006-0253-4.
3. Saller A, Maggi S, Romanato G, Tonin P, Crepaldi G. Diabetes and osteoporosis. Aging Clin Exp Res. 2008;20(18852539): 280-9.
4. van Daele PL, Stolk RP, Burger H, et al. Bone density in noninsulin- dependent diabetes mellitus. The Rotterdam Study. Ann Intern Med. 1995;122(7856988):409-14.
5. Yaturu S, Humphrey S, Landry C, Jain SK. Decreased bone mineral density in men with metabolic syndrome alone and with type 2 diabetes. Med Sci Monit. 2009;15(19114969):5-9.
6. Kao WHL, Kammerer CM, Schneider JL, Bauer RL, Mitchell BD. Type 2 diabetes is associated with increased bone mineral density in Mexican-American women. Arch Med Res. 2003; 34(14602507):399-406.
7. Majima T, Komatsu Y, Yamada T, et al. Decreased bone mineral density at the distal radius, but not at the lumbar spine or the femoral neck, in Japanese type 2 diabetic patients. Osteoporos Int. 2005;16(15558237):907-13.
8. Kahn A, Gibbons R, Perkins S, Gazit D. Age-related bone loss. A hypothesis and initial assessment in mice. Clin Orthop Relat Res. 1995;7641500:69-75.
9. Min J-Y, Min K-B, Paek D, Kang D, Cho S-I. Age curves of bone mineral density at the distal radius and calcaneus in Koreans. J Bone Miner Metab. 2010;28(19634016):94-9100.
10. Tung S, Iqbal J. Evolution, aging, and osteoporosis. Ann N Y Acad Sci. 2007;1116(18083942):499-506.
11. Barrett-Connor E, Holbrook TL. Sex differences in osteoporosis in older adults with non-insulin-dependent diabetes mellitus. JAMA. 1992;268(1453525): 3333-7.
12. Gerdhem P, Isaksson A, Akesson K, Obrant KJ. Increased bone density and decreased bone turnover, but no evident alteration of fracture susceptibility in elderly women with diabetes mellitus. Osteoporos Int. 2005;16(12):1506-12. doi:10.1007/s00198-005- 1877-5.
13. Schwartz AV, Sellmeyer DE, Ensrud KE, et al. Older women with diabetes have an increased risk of fracture: A prospective study. J Clin Endocrinol Metab. 2001;86(11231974):32-8.
14. de Liefde II, van der Klift M, de Laet CEDH, van Daele PLA, Hofman A, Pols HAP. Bone mineral density and fracture risk in type-2 diabetes mellitus: The Rotterdam Study. Osteoporos Int. 2005;16(15940395):1713-20.
15. Strotmeyer ES, Cauley JA, Schwartz AV, et al. Nontraumatic fracture risk with diabetes mellitus and impaired fasting glucose in older white and black adults: The health, aging, and body composition study. Arch Intern Med. 2005;165(16043679):1612-7.
16. Stroup DF, Berlin JA, Morton SC, et al. Meta-Analysis of observational studies in epidemiology: A proposal for reporting. Meta-Analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(10789670): 2008-12.
17. Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions. Version 5.0.2 [updated September 2009] ed: The Cochrane Collaboration; 2009.
18. Higgins JP, Thompson SG. Quantifying heterogeneity in a metaanalysis. Stat Med. 2002;21(11):1539-58. doi:10.1002/sim.1186.
19. Al-Elq AH, Sadat-Ali M. Diabetes mellitus and male osteoporosis. Is there a relationship? Saudi Med J. 2006;27(11):1729-33.
20. Al-Maatouq MA, El-Desouki MI, Othman SA, Mattar EH, Babay ZA, Addar M. Prevalence of osteoporosis among postmenopausal females with diabetes mellitus. Saudi Med J. 2004;25(10): 1423-7.
21. Buysschaert M, Cauwe F, Jamart J, et al. Proximal femur density in type 1 and 2 diabetic patients. Diabete Metab. 1992;18(1): 32-7.
22. Christensen JO, Svendsen OL. Bone mineral in pre- and postmenopausal women with insulin-dependent and non-insulindependent diabetes mellitus. Osteoporos Int. 1999;10(4):307-11.
23. Cutrim DM, Pereira FA, de Paula FJ, Foss MC. Lack of relationship between glycemic control and bone mineral density in type 2 diabetes mellitus. Braz J Med Biol Res. 2007;40(2):221-7.
24. Hadjidakis DJ, Mylonakis AM, Sfakianakis ME, Raptis AE, Raptis SA. Diabetes and premature menopause: Is their co-existence detrimental to the skeleton? Eur J Endocrinol. 2005; 152(3):437-42. doi:10.1530/eje.1.01853.
25. Hanley DA, Brown JP, Tenenhouse A, et al. Associations among disease conditions, bone mineral density, and prevalent vertebral deformities in men and women 50 years of age and older: Crosssectional results from the Canadian Multicentre Osteoporosis Study. J Bone Miner Res. 2003;18(4):784-90. doi:10.1359/jbmr. 2003.18.4.784.
26. Kwon DJ, Kim JH, Chung KW, Lee JW, Kim SP, Lee HY. Bone mineral density of the spine using dual energy X-ray absorptiometry in patients with non-insulin-dependent diabetes mellitus. J Obstet Gynaecol Res. 1996;22(8697346):157-62.
27. Nishitani H, Miki T, Morii H, et al. Decreased bone mineral density in diabetic patients on hemodialysis. Contrib Nephrol. 1991;90(1959351):223-7.
28. Okuno Y, Nishizawa Y, Sekiya K, Hagiwara S, Miki T, Morii H. Total and regional bone mineral content in patients with noninsulin dependent diabetes mellitus. J Nutr Sci Vitaminol (Tokyo). 1991;37 Suppl(1820443):43-9.
29. Yamaguchi T, Kanazawa I, Yamamoto M, et al. Associations between components of the metabolic syndrome versus bone mineral density and vertebral fractures in patients with type 2 diabetes. Bone. 2009;45(19446053):174-9.
30. Akin O, Gol K, Akturk M, Erkaya S. Evaluation of bone turnover in postmenopausal patients with type 2 diabetes mellitus using biochemical markers and bone mineral density measurements. Gynecol Endocrinol. 2003;17(12724015):19- 29.
31. Hampson G, Evans C, Petitt RJ, et al. Bone mineral density, collagen type 1 alpha 1 genotypes and bone turnover in premenopausal women with diabetes mellitus. Diabetologia. 1998; 41(9833939):1314-20.
32. Krakauer JC, McKenna MJ, Buderer NF, Rao DS, Whitehouse FW, Parfitt AM. Bone loss and bone turnover in diabetes. Diabetes. 1995;44(7789645):775-82.
33. Oz SG, Guven GS, Kilicarslan A, Calik N, Beyazit Y, Sozen T. Evaluation of bone metabolism and bone mass in patients with type-2 diabetes mellitus. J Natl Med Assoc. 2006;98(17052049): 1598-604.
34. Rishaug U, Birkeland KI, Falch JA, Vaaler S. Bone mass in noninsulin- dependent diabetes mellitus. Scand J Clin Lab Invest. 1995;55(7638560):257-62.
35. Sert M, Tetiker T, Kirim S, Soyupak S, Canataroglu A, Kocak M. Type 2 diabetes mellitus and osteopenia: Is there an association? Acta Diabetol. 2003;40(12861410):105-8.
36. Strotmeyer ES, Cauley JA, Schwartz AV, et al. Diabetes is associated independently of body composition with BMD and bone volume in older white and black men and women: The Health, Aging, and Body Composition Study. J Bone Miner Res. 2004;19(7):1084-91. doi:10.1359/JBMR.040311.
37. Shan PF, Wu XP, Zhang H, et al. Bone mineral density and its relationship with body mass index in postmenopausal women with type 2 diabetes mellitus in mainland China. J Bone Miner Metab. 2009;27(2):190-7. doi:10.1007/s00774-008- 0023-9.
38. Yamamoto M, Yamaguchi T, Yamauchi M, Kaji H, Sugimoto T. Bone mineral density is not sensitive enough to assess the risk of vertebral fractures in type 2 diabetic women. Calcif Tissue Int. 2007;80(6):353-8. doi:10.1007/s00223- 007-9003-7.
39. Schneider S, Schmitt G, Mau H, Schmitt H, Sabo D, Richter W. Prevalence and correlates of osteoarthritis in Germany. Representative data from the First National Health Survey. Orthopade. 2005;34(15912329):782-90.
40. Isaia G, Bodrato L, Carlevatto V, Mussetta M, Salamano G, Molinatti GM. Osteoporosis in type II diabetes. Acta Diabetol Lat. 1987;24(3439401):305-10.
41. Buday B, Horvath T, Kulcsar E, et al. Effect of progressive insulin resistance on the correlation of glucose metabolism and bone status. Orv Hetil. 2007;148(17561482):1127-33.
42. Horiuchi T, Nakamura T, Miyao M, et al. Bone mineral density in postmenopausal elderly women with type 2 diabetes. Nippon Ronen Igakkai Zasshi. 1995;32(8598632):756-60.
43. Komatsu Y, Majima T. Negative correlation between BMD and HbA1C in patients with type 2 diabetes. Clin Calcium. 2006;16(16883041):1327-31.
44. Sahin G, Bagis S, Cimen OB, Ozisik S, Guler H, Erdogan C. Lumbar and femoral bone mineral density in type 2 Turkish diabetic patients. Acta Medica (Hradec Kralove). 2001;44(4): 141-3.
45. Bonds DE, Larson JC, Schwartz AV, et al. Risk of fracture in women with type 2 diabetes: The Women's Health Initiative Observational Study. J Clin Endocrinol Metab. 2006; 91(16804043):3404-10.
46. Perez-Castrillon J-L, De Luis D, Martin-Escudero JC, Asensio T, del Amo R, Izaola O. Non-insulin-dependent diabetes, bone mineral density, and cardiovascular risk factors. J Diabetes Complications. 2004;18(15531180):317-21.
47. Sosa M, Dominguez M, Navarro MC, et al. Bone mineral metabolism is normal in non-insulin-dependent diabetes mellitus. J Diabetes Complications. 1996;10(8835919):201-5.
48. Tuominen JT, Impivaara O, Puukka P, Ronnemaa T. Bone mineral density in patients with type 1 and type 2 diabetes. Diabetes Care. 1999;22(7):1196-200.
49. Dennison EM, Syddall HE, Aihie Sayer A, Craighead S, Phillips DIW, Cooper C. Type 2 diabetes mellitus is associated with increased axial bone density in men and women from the Hertfordshire Cohort Study: Evidence for an indirect effect of insulin resistance? Diabetologia. 2004;47(15565368):1963-8.
50. Bridges MJ, Moochhala SH, Barbour J, Kelly CA. Influence of diabetes on peripheral bone mineral density in men: A controlled study. Acta Diabetol. 2005;42(15944841):82-6.
51. Schwartz AV, Sellmeyer DE, Strotmeyer ES, et al. Diabetes and bone loss at the hip in older black and white adults. J Bone Miner Res. 2005;20(4):596-603. doi:10.1359/JBMR.041219.
52. Rakic V, Davis WA, Chubb SAP, Islam FMA, Prince RL, Davis TME. Bone mineral density and its determinants in diabetes: The Fremantle Diabetes Study. Diabetologia. 2006;49(16518589): 863-71.
53. Hadzibegovic I, Miskic B, Cosic V, Prvulovic D, Bistrovic D. Increased bone mineral density in postmenopausal women with type 2 diabetes mellitus. Ann Saudi Med. 2008;28(18398285): 102-4.
54. Anaforoglu I, Nar-Demirer A, Bascil-Tutuncu N, Ertorer ME. Prevalence of osteoporosis and factors affecting bone mineral density among postmenopausal Turkish women with type 2 diabetes. J Diabetes Complications. 2009;23(18413190):12-7.
55. Shan PF, Wu XP, Zhang H, Cao XZ, Yuan LQ, Liao EY. Agerelated bone mineral density, osteoporosis rate and risk of vertebral fracture in mainland Chinese women with type 2 diabetes mellitus. J Endocrinol Invest. 2011;34(3):190-6. doi:10.3275/ 7239.
56. Zhou Y, Li Y, Zhang D, Wang J, Yang H. Prevalence and predictors of osteopenia and osteoporosis in postmenopausal Chinese women with type 2 diabetes. Diabetes Res Clin Pract. 2010;90(3):261-9. doi:10.1016/j.diabres.2010. 09.013.
57. Javed F, Yu W, Thornton J, Colt E. Effect of fat on measurement of bone mineral density. Int J Body Compos Res. 2009;7(1): 37-40.
58. Evans EM, Mojtahedi MC, Kessinger RB, Misic MM. Simulated change in body fatness affects Hologic QDR 4500A whole body and central DXA bone measures. J Clin Densitom. 2006; 9(16931350):315-22.
59. Reid IR. Relationships between fat and bone. Osteoporos Int. 2008;19(5):595-606. doi:10.1007/s00198-007-0492-z.
60. Kanabrocki EL, Hermida RC, Wright M, et al. Circadian variation of serum leptin in healthy and diabetic men. Chronobiol Int. 2001;18(2):273-83.
61. Hamrick MW, Della-Fera MA, Choi YH, Pennington C, Hartzell D, Baile CA. Leptin treatment induces loss of bone marrow adipocytes and increases bone formation in leptin-deficient ob/ob mice. J Bone Miner Res. 2005;20(6):994-1001. doi:10.1359/ JBMR.050103.
62. Steppan CM, Crawford DT, Chidsey-Frink KL, Ke H, Swick AG. Leptin is a potent stimulator of bone growth in ob/ob mice. Regul Pept. 2000;92(1-3):73-8.
63. Gordeladze JO, Drevon CA, Syversen U, Reseland JE. Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: Impact on differentiation markers, apoptosis, and osteoclastic signaling. J Cell Biochem. 2002; 85(11968022):825-36.
64. Cornish J, Callon KE, Bava U, et al. Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J Endocrinol. 2002;175(12429038):405-15.
65. Holloway WR, Collier FM, Aitken CJ, et al. Leptin inhibits osteoclast generation. J Bone Miner Res. 2002;17(11811550): 200-9.
66. Berner HS, Lyngstadaas SP, Spahr A, et al. Adiponectin and its receptors are expressed in bone-forming cells. Bone. 2004; 35(15454091):842-9.
67. Thommesen L, Stunes AK, Monjo M, et al. Expression and regulation of resistin in osteoblasts and osteoclasts indicate a role in bone metabolism. J Cell Biochem. 2006;99(16721825): 824-34.
68. Cornish J, Callon KE, Watson M, Lin Jm, Reid IR. Resistin, an adipocytokine, stimulates osteoblast and osteoclast proliferation. Bone. 2006;38(3, Supplement 1):9. doi:10.1016/j.bone.2006.01.071
69. Luo XH, Guo LJ, Xie H, et al. Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway. J Bone Miner Res. 2006;21(10):1648-56. doi:10.1359/jbmr.060707.
70. Oshima K, Nampei A, Matsuda M, et al. Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. Biochem Biophys Res Commun. 2005;331(15850790):520-6.
71. Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001;86(5):1930-5. doi:10.1210/jc.86.5.1930.
72. Gómez-Ambrosi J, Frühbeck G. Evidence for the involvement of resistin in inflammation and cardiovascular disease. Curr Diabetes Rev. 2005;1:227-34.
73. Richards JB, Valdes AM, Burling K, Perks UC, Spector TD. Serum adiponectin and bone mineral density in women. J Clin Endocrinol Metab. 2007;92(4):1517-23. doi:10.1210/jc.2006- 2097.
74. Pun KK, Lau P, Ho PW. The characterization, regulation, and function of insulin receptors on osteoblast-like clonal osteosarcoma cell line. J Bone Miner Res. 1989;4(2692404):853-62.
75. Kawai M, Rosen CJ. Insulin-like growth factor-I and bone: Lessons from mice and men. Pediatr Nephrol. 2009;24(7):1277-85. doi:10.1007/s00467-008-1040- 6.
76. Langlois JA, Rosen CJ, Visser M, et al. Association between insulin-like growth factor I and bone mineral density in older women and men: The Framingham Heart Study. J Clin Endocrinol Metab. 1998;83(12):4257-62.
77. Zhao G, Monier-Faugere MC, Langub MC, et al. Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: Increased trabecular bone volume without increased osteoblast proliferation. Endocrinology. 2000;141(10875273): 2674-82.
78. Wasnich RD, Benfante RJ, Yano K, Heilbrun L, Vogel JM. Thiazide effect on the mineral content of bone. N Engl J Med. 1983;309(6):344-7. doi:10.1056/NEJM198308113090605.
79. Schoofs MW, van der Klift M, Hofman A, et al. Thiazide diuretics and the risk for hip fracture. Ann Intern Med. 2003; 139(6):476-82.
80. Pasco JA, Kotowicz MA, Henry MJ, Sanders KM, Nicholson GC. Statin use, bone mineral density, and fracture risk: Geelong Osteoporosis Study. Arch Intern Med. 2002;162(5):537-40.
81. Schoofs MW, Sturkenboom MC, van der Klift M, Hofman A, Pols HA, Stricker BH. HMG-CoA reductase inhibitors and the risk of vertebral fracture. J Bone Miner Res. 2004;19(9):1525-30. doi:10.1359/JBMR.040607.
82. Schurman L, McCarthy AD, Sedlinsky C, et al. Metformin reverts deleterious effects of advanced glycation end-products (AGEs) on osteoblastic cells. Exp Clin Endocrinol Diabetes. 2008;116(6):333-40. doi:10.1055/s-2007- 992786.
83. Zhou Z, Immel D, Xi CX, et al. Regulation of osteoclast function and bone mass by RAGE. J Exp Med. 2006;203(4):1067-80. doi: 10.1084/jem.20051947.
84. Burghardt AJ, Issever AS, Schwartz AV, et al. High-resolution peripheral quantitative computed tomographic imaging of cortical and trabecular bone microarchitecture in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2010;95(11):5045-55. doi:10.1210/jc.2010-0226.
85. Brownlee M. The pathobiology of diabetic complications: A unifying mechanism. Diabetes. 2005;54(15919781):1615-25.
86. Yamaguchi T, Sugimoto T. Bone metabolism and fracture risk in type 2 diabetes mellitus [review]. Endocr J. 2011;58(8):613-24.
87. Evans WJ, Campbell WW. Sarcopenia and age-related changes in body composition and functional capacity. J Nutr. 1993;123(2 Suppl):465-8.
88. SchwartzAV,Vittinghoff E, BauerDC, et al.Association ofBMDand FRAX score with risk of fracture in older adults with type 2 diabetes. JAMA. 2011;305(21):2184-92. doi:10.1001/jama.2011.715.
89. Giangregorio LM, Leslie WD, Lix LM, et al. FRAX underestimates fracture risk in patients with diabetes. J Bone Miner Res. 2011;. doi:10.1002/jbmr.556.
90. Hippisley-Cox J, Coupland C. Predicting risk of osteoporotic fracture in men and women in England and Wales: Prospective derivation and validation of QFractureScores. BMJ. 2009;339: B4229. doi:10.1136/bmj.b4229.